Condition: Oropharynx Cancer · Sponsor: The Institute of Molecular and Translational Medicine, Czech Republic
This study defines the prevalence of oral infection with high-risk human papillomaviruses (hrHPV) in individuals over 40 years of age in the Czech Republic. It also establishes an effective methodology for oropharyngeal carcinoma screening and optimization of screening and testing procedures.
This description comes directly from the study's public registry record.
Vladimira Koudelakova, Ph.D. · +420585632089 · vladimira.koudelakova@upol.cz
Always discuss trial participation with your own doctor first.
| Masaryk Memorial Cancer Institute | Brno, Czechia | Not Yet Recruiting |
| Stomatologická klinika, Fakultní nemocnice u sv. Anny | Brno, Czechia | Recruiting |
| Stomatologické centrum ARTDENT s.r.o. | Jihlava, Czechia | Recruiting |
| Klinika zubního lékařství Fakultní nemocnice Olomouc | Olomouc, Czechia | Recruiting |
| CLINIQ Dejvice | Prague, Czechia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07033091